Record Fiscal 2024 Gross Profit Reduced Net Convertible Debt by ~$300 Million in Fiscal 2024 Fiscal 2024 Net Revenue Reaches $789 Million, Led by Cannabis Net Revenue of $273 Million and Beverage-Alcohol Net Revenue of $202 Million Successfully Executing on Diversified Lifestyle Business Strategy;Tilray Cannabis, Tilray Beverages, Tilray Spirits and Tilray Wellness NEW YORK and LEAMINGTON, Ontario, and NEÜMUNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “ ...

Tilray (NASDAQ:TLRY) stock is on the move Monday as investors in the cannabis company react to it securing a trading license in Germany for its Aphria RX subsidiary.With this trading license, Aphria RX is now able to sell and distribute medical cannabis products to a wide range of locations. That includes pharmacies, hospitals, and medical wholesalers in Germany.Investors will note that this builds on the cannabis cultivation license that Tilray already has in Germany. This gives it a strong foothold in the ...

NEUMÜNSTER, Germany, July 29, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global leader in medical cannabis research, cultivation, production, and distribution, today announced that Aphria RX GmbH ("Aphria RX") has received a trading license, which will allow it to sell and distribute a broad range of medical cannabis products to pharmacies, hospitals, and medical wholesalers throughout Germany. "This milestone of Aphria RX obtaining both its new cultivation license as ...

文章核心观点 - 公司预计第四季度收入同比增长22.5%,达到2.257亿美元,但净利润仍预计亏损2美分 [1][2] - 公司过去4个季度平均盈利超出预期50%,上一季度更是超出100% [3] - 公司产品创新丰富,包括医用大麻、含THC饮料和药品级药物,有助于开拓新市场 [4] - 公司通过收购HEXO和Truss Beverage等实现有机增长和战略性并购,以最大化收入机会 [4] - 公司在北美、欧洲和其他地区的广泛布局降低了市场风险,有利于把握不同经济环境下的机会 [5] 公司表现 - 公司在加拿大市场占据领先地位,并拥有成熟的成人用品牌,有望从监管变革中获益 [6] - 公司在德国等欧洲医疗大麻市场占据领先地位,并利用当地种植设施把握市场扩张机会 [7] 行业风险 - 行业仍面临监管不确定性和市场风险,如价格压缩和高税收等因素挤压利润空间 [8]

文章核心观点 - 葡萄牙医疗大麻公司Tilray Brands获得葡萄牙批准新的医用大麻提取物Tilray Oral Solution THC10:CBD10 [1][2] - Tilray Medical是全球医疗大麻行业的领导者,提供多样化的欧盟GMP认证医用大麻产品 [3] - Tilray Medical从最早获得加拿大医用大麻生产许可,到在欧洲建立首个GMP认证大麻生产设施,现已成为全球20多个国家和5大洲最大的医用大麻品牌供应商之一 [4] - Tilray Brands是一家全球领先的生活方式和消费品公司,在多个国家和地区经营,致力于通过创新、优质和广受欢迎的品牌来改善人们的生活 [5] 公司概况 - Tilray Brands是一家全球领先的生活方式和消费品公司,在加拿大、美国、欧洲、澳大利亚和拉丁美洲等地区经营 [5] - 公司致力于通过创新、优质和广受欢迎的品牌来改善人们的生活,提供全面的大麻产品、麻类食品和手工饮料等 [5] - Tilray Medical是公司旗下的医疗大麻业务,是全球医疗大麻行业的领导者,提供多样化的欧盟GMP认证医用大麻产品 [3][4] - Tilray Medical从最早获得加拿大医用大麻生产许可,到在欧洲建立首个GMP认证大麻生产设施,现已成为全球20多个国家和5大洲最大的医用大麻品牌供应商之一 [4] 新产品获批 - Tilray Brands的子公司Tilray Medical获得葡萄牙批准新的医用大麻提取物Tilray Oral Solution THC10:CBD10 [1][2] - 这是Tilray Medical继早前获批Tilray Medical whole flower THC 18和首个大麻提取物后,在葡萄牙获批的第二个新医用大麻产品 [1][2] - 这标志着Tilray Medical在满足患者医疗需求、提供高质量大麻产品和治疗方案方面取得重大进展 [2]

The most recent trading session ended with Tilray Brands, Inc. (TLRY) standing at $1.89, reflecting a -1.56% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss of 0.16%. Elsewhere, the Dow lost 0.14%, while the tech-heavy Nasdaq lost 0.06%.Prior to today's trading, shares of the company had gained 15.66% over the past month. This has outpaced the Consumer Staples sector's gain of 1.5% and the S&P 500's gain of 1.96% in that time.The upcoming earnings release of Tilra ...

Tilray Brands (NASDAQ:TLRY) stock jumped almost 3% early on July 22 after it got good news from Germany. The marijuana and beer company received a cultivation license from German authorities. They were acting under a new Cannabis Act that legalized possession. TLRY stock opened at $1.83 per share this morning, and its market capitalization rose to over $1.5 billion. The stock has slid a bit since opening and is down to just about 1.4% up as of this writing. Pot and Beer Tilray is down 22% in 2024 as it cont ...

Tilray's Aphria RX Facility in Germany Granted New Cannabis Cultivation License, Allowing for ~5x Production Increase and New Strains to Enhance Patient Access Across the Country Aphria RX Designed with Guidance from Renowned Cannabis Grower of Broken Coast Cannabis NEUMÜNSTER, Germany, July 22, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that its Germany cannabis cultivation ...

ATLANTA, July 19, 2024 (GLOBE NEWSWIRE) -- Calling all 17s1! SweetWater Brewing Company ("SweetWater Brewing" or "SweetWater"), one of the largest craft brewers in the Southeast and a subsidiary of Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), is teaming up with Atlanta United to release Rowdy Peach IPA, a lively and vibrant new brew that celebrates the 5-Stripes and its passionate legion of supporters. With its fresh juicy peach aromas and 6.8% ABV, this medium body IPA will get ...

NEW YORK and WINNIPEG, Manitoba, July 17, 2024 (GLOBE NEWSWIRE) -- Manitoba Harvest, the global leader in hemp foods and a wholly-owned subsidiary of Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), announced its second series of its proprietary and revolutionary Organic Bioactive Fiber in partnership with Brightseed®, the bioactives company on a mission to illuminate nature to restore human health. Unveiling two new flavors —Coffee and Chocolate—the new products are intended to elev ...